Burney Company’s Apellis Pharmaceuticals APLS Stock Holding History

Burney Company’s Portfolio APLS Stock Details APLS Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	–	Sell	-61,578	Closed	-$2.48M	–	610
2026 Q1	$2.48M	Buy	+61,578	New	+$1.33M	0.08%	195

Other funds holding APLS

IFP Advisors Tampa, Florida $5.54B AUM 27.43% 1-Year Est. Return

Burney Company's APLS Position: Q2 2026 in Review

Burney Company sold out of Apellis Pharmaceuticals (APLS) in Q2 2026, closing a stake of 61,578 shares — an estimated $2.48M sold.

Burney Company first reported a position in APLS in Q1 2026 and held it in 1 quarter. The position peaked at $2.48M in Q1 2026. 1 fund tracked by Wall St. Rank holds APLS as of Q2 2026.

Burney Company reported no remaining Apellis Pharmaceuticals position as of Q2 2026 after selling out during the quarter.
Burney Company sold 61,578 Apellis Pharmaceuticals shares in Q2 2026, an estimated $2.48M.
Burney Company first reported a position in Apellis Pharmaceuticals in Q1 2026 and held it in 1 quarter.
Burney Company's Apellis Pharmaceuticals position peaked at $2.48M in Q1 2026.
1 fund tracked by Wall St. Rank held Apellis Pharmaceuticals as of Q2 2026.

Based on Burney Company's 13F filing for Q2 2026, filed 15 Jul 2026.